Sort by
Refine Your Search
-
Biomaterials Division opportunity location 50.64.41.B7206 Gaithersburg, MD NIST only participates in the February and August reviews. Advisers name email phone David J. Ross [email protected] 301.975.2525
-
and biomaterials as therapeutics and devices. Project: RNA medicines have gained considerable momentum in the past few years with the approval of Onpattro and the COVID-19 messenger RNA vaccines. While
-
of multiple cell lines (mouse or human stem cells, cortical cells, etc.), cell culture assays, flow cytometry and immunocytochemistry, such as DNA/RNA/Protein isolation and electrophoresis, PCR, rtPCR, qPCR
-
imaging (e.g., optical, X-rayCT, photoacoustic imaging) of biomaterials and biomaterials-modulated processes, biomaterials transcriptomics (e.g., single-cell RNA sequencing), biomaterials innovation
-
encourage people working in the following areas to apply: Synthetic Biology RNA Therapeutics Tissue Engineering/Regenerative Medicine Biomaterials and Biomimetics Chemical Biology ABOUT XJTLU In 2006 Xi’an
-
analysis (e.g., single cell RNA-seq), quantitative cell biology, signaling and metabolic engineering, mechanotransduction, and/or membrane transporters. Regenerative medicine and biomaterials
-
OBJECTIVE The Acharya lab focuses on developing novel biomaterials from metabolites. These biomaterials are tested for their ability to modulate metabolism of immune cells, and test if these can modulate